Delivering confidence in precision medicine: strategies for potency, safety, and long-term success
This webinar explores the scientific and analytical capabilities required to support precision medicine programs across advanced modalities such as cell and gene therapy, and complex therapeutic areas, including oncology and neurology.
Join an expert panel as they explore key considerations in potency assessment, safety monitoring and evidence generation, with a focus on building integrated strategies that support development from early research through long-term follow-up.
Register now to explore real-world perspectives on:
- Defining and measuring clinically meaningful potency across CAR-T, in vivo gene therapy, and other CGT modalities, and how potency strategy evolves from early development through regulatory submission
- Designing safety monitoring programs that extend beyond clinical trials, including long-term follow-up, registries, and modality-specific risks such as immunogenicity and insertional mutagenesis
- Integrating analytical data, clinical endpoints, and real-world evidence into a cohesive evidence strategy that supports regulatory and payer expectations
How manufacturing consistency, analytical controls, and cross-functional alignment contribute to sustained program confidence post-approval.